9. Former name or former address, if changed since last report
-
10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA
Title of Each Class
Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
Common
3,159,292,441
11. Indicate the item numbers reported herein
Item 9 (Other Events)
The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.
MEDCO Holdings, Inc.MED
PSE Disclosure Form 4-11 - Change in Number of Issued and Outstanding Shares References: Section 4.4 of the Revised Disclosure Rules
Subject of the Disclosure
Change in number of Issued and Outstanding Shares of Medco Holdings, Inc.
Background/Description of the Disclosure
As previously disclosed, Bonham Strand Investments Ltd. and Mr. Xu Hanjiang subscribed to a total of 2,459,292,441 shares of the Corporation, with the aggregate par value of Php122,964,,622.05. The subscription was subject to the approval of the Corporation's application for increase in capital stock.
On 24 April 2018, the Securities and Exchange Commission approved the increase in capital. Accordingly, the said shares were issued in favor of Bonham Strand Investments Ltd. and Mr. Xu Hanjiang.
Change(s) in Number of Issued and Outstanding Shares